Shandong Sinobioway Biomedicine Co., Ltd. (002581.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap4.95B
Enterprise Value4.77B
P/E Ratio-17.03
PEG Ratio0.75
Price/Sales Ratio8.03
Price/Book Ratio1.26
Enterprise/Revenue7.63
Enterprise/EBITDA-15.71

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.47
Operating Margin-0.66
AD

Management Effectiveness

Return On Assets-0.06
Return On Equity-0.07

Income Statement

Revenue274.81M
Revenue/Share0.43
Gross Profit145.21M
EBITDA-135.93M
Net Income-116.28M
Diluted EPS-0.18

Balance Sheet

Total Cash153.88M
Total Cash/Share0.23
Total Debt41.02M
Total Debt/Equity0.02
Current Ratio3.65
Book Value Per Share2.89

Price History

52-Week Change-52.22
52-Week High9.25
52-Week Low3.04
Moving Average 50 Days3.68
Moving Average 200 Days6.52

Statistics

Average Volume9.35M
Shares Outstanding659.74M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.01
Last Split Factor2:1
Last Split DateJuly 10, 2015
AD